iShares Biotechnology ETF
369 hedge funds and large institutions have $5.23B invested in iShares Biotechnology ETF in 2014 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 107 increasing their positions, 114 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
369
Holders Change
+52
Holders Change %
+16.4%
% of All Funds
9.85%
Holding in Top 10
25
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+47.06%
% of All Funds
0.67%
New
83
Increased
107
Reduced
114
Closed
28
Calls
$448M
Puts
$821M
Net Calls
-$373M
Net Calls Change
-$239M
Top Buyers
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$630M |
| 2 |
2
Citigroup
New York
|
$332M |
| 3 |
3
Morgan Stanley
New York
|
$540M |
| 4 |
4
Barclays
London,
United Kingdom
|
$90.4M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$289M |
